Taskaynatan, H., Kucukzeybek, Y., Yildiz, Y., Salman, T., Oflazoglu, U., Varol, U., Alacacioglu, A., Saray, S., Ozdemir, O. and Oktay Tarhan, M. 2021. Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study . Annals of Medical Research. 27, 1 (May 2021), 0029–0033.